Report #2895313

Received May 4, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: FL
Recovered: Unknown
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARCEL	VARICELLA (VARIVAX)	MERCK & CO. INC.	UNK	Z016561	—

Symptoms (2)

No adverse eventProduct storage issue

Symptom narrative

the patient was administered VARIVAX that has suffered a temperature excursion; No additional AE/ no PQC; This spontaneous report was received from pharmacist and refers to a patient of unknown age and gender. The patient's medical history, current conditions and concomitant therapies were not reported. On an unknown date, the patient was vaccinated with an improper storage dose of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX), (lot #Z016561, who had been verified to be an valid lot #, expiration date reported and validated as 28-OCT-2027) 0.5 ml/ series (exact dose, anatomical route of administration and frequency were not reported) as prophylaxis; the vaccine was reconstituted with sterile diluent (Hollister-Stier STERILE DILUENT). The vaccine was storage at temperature 12F, with a time frame 2 hours 30 minutes 0 seconds. There was no information about previous temperature excursion (product storage issue). No adverse events reported.

Other medications

Sterile diluent